ABSTRACT
Introduction
Laparoscopic surgery is less damaging to immune functions and has lower rates of systemic inflammation as it is a less invasive method, compared to open abdominal operations.
Nonetheless, increased intra-abdominal pressure during pneumoperitoneum and inflation-deflation can lead to splanchnic ischemia-reperfusion and oxidative stress. Hemodynamic changes and the impact of carbon dioxide (CO 2 ) may also exacerbate oxidative stress during pneumoperitoneum 1 Other than the well-established effects on blood coagulation, studies have evaluated many other activities of LMWH, including anti-inflammatory activity [5] [6] [7] [8] [9] [10] [11] . These studies have demonstrated that enoxaparin could be effective for managing many inflammatory disorders including, inflammatory reaction after pediatric cataract surgery 5 , ST-segment elevated myocardial infarction 6 , mast cell-mediated allergic inflammation 7 , allergic asthma 8, 9 , and acute colitis
11
. Enoxaparin has also been shown to be effective against fibrosis progression in the rat model of cirrhosis
12
, CCL 4 -induced necrosis and apoptosis of the liver
13
, dimethylnitrosamine (DMN)-induced liver fibrosis 14 , radiationinduced liver toxicity
15
, and experimental cholestatic liver injury 16 .
In addition, the protective effects of heparin have been shown in an experimental hepatic ischemia-reperfusion model 17 .
Based on these effects of enoxaparin, the present study was conducted to investigate the potential protective effects of enoxaparin against the adverse events of high pressure CO 2 pneumoperitoneum. The main outcome was to evaluate the effects of enoxaparin on histopathological changes in liver tissue caused by pneumoperitoneum. The possible effects on biochemical parameters and oxidative status were also assessed.
Methods
This study was conducted in the Husnu Sakal
Experimental and Clinical Practice Center, Ankara, Turkey.
The procedures in this experimental study were performed in Medical GmbH, Gildenweg, Germany) into the abdomen and 90 min of anesthesia with no gas insufflation, maintaining intraabdominal pressure at 0 mmHg. The animals in Group 2 (control, n=12) and Group 3 (enoxaparin group, n=14) were subjected to 90 min of 14 mmHg CO 2 pneumoperitoneum. Enoxaparin (100 u/ kg) was administered subcutaneously to the rats in Group 3 1 hour before the operation. The pneumoperitoneum was created using an electronic insufflator (Ackermann Instrumente, 15-1711, high performance insufflation system, Germany) through a 7-gauge Veress needle maintaining intra-abdominal pressure at 14 mmHg.
After 90 min of pneumoperitoneum, the Veress needles were withdrawn and the abdomens of the rats were desufflated. The rats were then allowed free movement for reperfusion through 60 min.
At the end of this period, blood and liver samples were obtained for biochemical and histopathological examination. . The scoring system of these parameters is given in Table 1 . MDA levels were calculated using the fluorometric method, as described by Wasowicz et al. 19 After the reaction of thiobarbituric acid (TBA) with MDA, the reaction product was extracted in butanol and was measured spectrofluorometrically at wavelengths of 525 nm for excitation and 547 nm for emission. MDA levels were presented as μmol/g wet tissue.
AOPP were determined according to method .05 was considered to be statistically significant.
Results
The mean histopathological scores of the groups are given in Table 2 . When statistical analyses of the histopathological scores were performed, it was found that congestion and necrosis scores in the enoxaparin-treated group were significantly lower than the scores in the control group (p<0.05 for both parameters).
The congestion and necrosis scores of the sham group were also significantly lower than those of the control group (p<0.05 for both scores). There was no significant difference between the necrosis scores of the sham and enoxaparin groups (p>0.05), but the congestion scores of the enoxaparin group were higher than those of the sham group (p<0.05). No vacuolization was detected in any group (mean vacuolization score was 0.00 for all groups). The mean levels of the liver function tests (AST, ALT and ALP) are summarized in Table 3 . There was no significant difference in ALP levels between the groups (p>0.05). The highest tissue ALP levels were detected in the control group. The levels in the enoxaparin group were lower than those of the control group, but this difference was not statistically significant (p>0.05).
The differences between the sham and other groups were significant for ALT and AST levels (p<0.05). The highest AST and ALT values were found in the control group. The use of enoxaparin decreased these levels, but the difference between the control and enoxaparin groups was not statistically significant (p>0.05). The mean levels of the oxidative stress parameters for the liver (MDA, AOPP and TFOP) are summarized in Table 4 . For MDA, AOPP, and TFOP levels, the differences between the sham and other groups were significant (p<0.05 for all parameters). The highest MDA, AOPP, and TFOP values were found in the control group. The use of enoxaparin decreased the levels of all oxidative stress parameters, but the difference between the control and enoxaparin groups was not statistically significant (p>0.05 for all parameters). 
Discussion
The impact of any surgical procedure on the human body can be described as surgical stress. As a result of surgical procedures, there may be a complex physiological stress response including the activation of inflammatory, metabolic, endocrine, and immunological mediators. In recent years, there has been increasing use of laparoscopic surgery for diagnostic and therapeutic purposes. A reduced requirement for analgesia, shorter hospital stay, decreased blood loss, less operative morbidity, and better cosmesis are just some of the patient-related benefits provided by this type of surgery. The smaller abdominal incisions and less tissue manipulation required by minimally invasive surgery result in less trauma and therefore, a lower stress response is expected.
In the application of laparoscopic surgery, pneumoperitoneum is necessary for adequate visualization and operative manipulation. Following insufflation and deflation of CO 2 , ischemia-reperfusion injury develops, thereby inducing oxidative stress 22, 23 .
The level of intra-abdominal pressure may have an effect on the visceral organ injury. In a study by Komori et al. 22 , it was demonstrated that pneumoperitoneum at high pressure had a negative effect on postoperative liver regeneration but when the pressure was maintained at a low level, no adverse effects were observed. In all the parameters, there was no significant difference between the control and low-pressure groups. In the high pressure group, a significant decrease was determined in the rate of liver regeneration and mitotic count. In addition, hepatocellular damage, serum MDA and serum IL-6 were determined to be significantly higher in the high-pressure group compared with the control and/or low-pressure groups. It was concluded that the application of high-pressure pneumoperitoneum before 70% liver resection results in impaired postoperative liver regeneration.
Compared to unfractionated heparin (UFH), lowmolecular-weight heparin (LMWH) enoxaparin provides more stable anticoagulation, without any requirement for therapeutic monitoring. In the same way as UFH, Enoxaparin binds to and potentiates antithrombin action, as an endogenous inhibitor of coagulation factors XIa, IXa, Xa and IIa. Through the inhibition of these serine proteases, the coagulation cascade is inhibited, thereby preventing blood clot formation 24 .
Beyond the anticoagulative effects, the anti-inflammatory activities of LMWHs have been shown in several studies [5] [6] [7] [8] [9] [10] [11] . These studies have demonstrated that enoxaparin could be effective for managing many inflammatory disorders including inflammatory reaction after pediatric cataract surgery
5
, ST-segment elevated myocardial infarction 6 , mast cell-mediated allergic inflammation 7 , allergic asthma 8, 9 , and acute colitis
11
. Enoxaparin has also been shown to be effective against many hepatic disorders and has a well-established hepatoprotective effect [12] [13] [14] [15] [16] [17] .
In a study by Kukner et al. 13 the beneficial effects of enoxaparin against necrosis and apoptosis were investigated in the early stage of CCL 4 -induced liver damage. Enoxaparin was determined to reduce necrosis, apoptosis, and the number of mast cells but no effect was observed on lipid droplets in hepatocytes.
Enoxaparin has been shown to have beneficial effects on fibrosis progression and regenerative activity in the cirrhosis model
12
. In a study by Lee et al. 14 In a previous study by the current authors 25 , an evaluation was made of the effects of low dose enoxaparin on plasma MDA levels and liver function tests during laparoscopic cholecystectomy. At 20 mins after deflation, MDA levels were seen to have significantly increased in the control group compared with the enoxaparin group. A significant increase in plasma MDA concentrations compared to the initial levels was determined in the control group. It was concluded that a mini dose of enoxaparin prevented the MDA increase after laparoscopic cholecystectomy without causing any bleeding disorder while having no effect on serum ALT and AST elevations. In the current study, significant differences were seen between the sham and other groups in respect of the ALT and AST levels. The highest AST and ALT values were determined in the control group. While enoxaparin was determined to have decreased these levels, the difference between the control and enoxaparin groups was not statistically significant. No significant difference was found in the ALP levels between the groups. The highest tissue ALP levels were in the control group and although the levels in the enoxaparin group were lower than those of the control group, the difference was not statistically significant. The results obtained in the current study were similar to the results of our previous study 25 The conclusion of that study was that these elevated enzyme levels could be attributed in the main to the negative effects of the pneumoperitoneum on hepatic blood flow.
In another study, using indocyanine green elimination tests (ICG-PDR), Eryilmaz et al. 27 examined the effects on liver functions of insufflation at different pressures. Measurements of serum AST, ALT, and total bilirubin levels were taken preoperatively, and at postoperative 1 hour and 24 hours. The results showed that 14mmHg pressure pneumoperitoneum decreased blood flow to the liver and increased postoperative 1-hour serum AST and ALT levels. It was therefore suggested that 10mmHg pressure pneumoperitoneum is superior to 14mmHg in laparoscopic cholecystectomy.
In the present study, the differences between the sham and other groups were significant for ALT and AST levels (p<0.05). The highest AST and ALT values were found in the control group. The use of enoxaparin decreased these levels, but the difference between the control and enoxaparin groups was not statistically significant (p>0.05). Although the minimal changes of liver enzymes during laparoscopic procedures do not seem to be clinically important, care should be taken before deciding to perform laparoscopic operations in patients with liver diseases. as it has been reported to be 10-100 times more sensitive than the colorimetric thiobarbituric acid-reactive substances assay.
Different conditions associated with systemic oxidative stress are known to significantly increase the levels of fluorescent oxidation products 21 .
In the current study, the levels of MDA, AOPP, and TFOP were measured for the evaluation of oxidative status and the effects of enoxaparin on oxidative stress during high-pressure pneumoperitoneum. The differences between the sham and other groups were significant for all parameters (p<0.05). The highest levels of oxidative stress parameters were found in the control group, in other words, high-pressure pneumoperitoneum increased the oxidative stress. Although the use of enoxaparin decreased these values, the differences between the control and enoxaparin groups were not statistically significant (p>0.05 for all parameters).
In the light of these results, it was concluded that enoxaparin had a partial antioxidant effect.
The beneficial effects of enoxaparin was thought to be primarily due to its anti-inflammatory effect, together with a partial antioxidant effect. Enoxaparin has been used widely preoperatively for the prevention of thromboembolism in surgical clinics all over the world.
Conclusions
Enoxaparin ameliorated the harmful effects of high pressure CO 2 pneumoperitoneum on the liver. The use of enoxaparin in laparoscopic operations for its hepatoprotective effect might be recommended after prospective randomized clinical trials.
